Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

A breakthrough in the fight against Alzheimer's was made by researchers at the University of Pittsburgh, where a test was ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

A research team at the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has developed a new ...

Researchers from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) have found that tau protein and beta-amyloid – two pathological hallmarks of Alzheimer’s disease – ...

Researchers say CSF biomarker test correlates with the severity of cognitive decline, independent of other factors, including brain amyloid deposition.

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...

New serine biomarkers show promise for early Alzheimer's detection, linking tau assemblies to cognitive decline and offering ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

A new biomarker test developed at the University of Pittsburgh could help doctors doctors detect signs of Alzheimer's years sooner, according to research published Monday in Nature Medicine.

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms ...